Literature DB >> 31575675

Ways to unwind with HROB, a new player in homologous recombination.

Giulia Saredi1, John Rouse1.   

Abstract

Homologous recombination (HR) is an important route for repairing DNA double-strand breaks (DSBs). The early stages of HR are well understood, but later stages remain mysterious. In this issue of Genes & Development, Hustedt and colleagues (pp. 1397-1415) reveal HROB as a new player in HR required for recruitment of the MCM8-9 complex, which is paralogous to the MCM2-7 replicative helicase. HROB functions closely with MCM8-9 to promote postsynaptic DNA repair synthesis. This study sheds valuable light on late events in HR and suggests that HROB may load MCM8-9 onto HR intermediates to facilitate the DNA unwinding required for DNA repair synthesis.
© 2019 Saredi and Rouse; Published by Cold Spring Harbor Laboratory Press.

Entities:  

Keywords:  CRISPR screens; DNA damage; DNA repair; DNA synthesis; cisplatin; germ cells; helicase; homologous recombination; infertility

Mesh:

Substances:

Year:  2019        PMID: 31575675      PMCID: PMC6771384          DOI: 10.1101/gad.331850.119

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


Homologous recombination (HR) is a major route for repairing DNA double-strand breaks (DSBs) (Prakash et al. 2015). HR starts with resection of broken DNA ends, involving nucleases and helicases. The resulting overhangs, coated by RAD51 to yield a nucleoprotein filament, invade the intact sister chromatid, searching for a homologous sequence. The pairing of RAD51-coated single-stranded DNA (ssDNA) with the donor strand (termed synapsis) results in the displacement of the strand complementary to the donor (forming a structure called a “D loop”) and the establishment of a RAD51-bound heteroduplex species that primes DNA repair synthesis (Fig. 1). The postsynaptic stages of HR are poorly understood, but a number of proteins are involved at this stage specifcially. For example, the MCM8 and MCM9 proteins, which are related to the subunits of the hexameric MCM2–7 replicative helicase, have been implicated in postsynaptic DNA synthesis. In contrast to MCM2–7, the MCM8–9 complex is dispensable for bulk DNA replication (Griffin and Trakselis 2019). The residual DNA synthesis that is maintained in MCM2-depleted cells requires MCM8–9, but this reflects DNA repair synthesis occurring during HR-mediated repair of the high level of DSBs that occur upon MCM2 depletion (Natsume et al. 2017). Importantly, MCM8–9 was shown to act downstream from RAD51 in the HR-mediated repair of DSBs induced by nuclease overexpression, in meiotic HR, and during the HR stage of DNA interstrand cross-link (ICL) repair (Lutzmann et al. 2012; Nishimura et al. 2012; Natsume et al. 2017). The dominant mode of ICL repair is initiated by collision of replisomes with ICLs, resulting in programmed formation of DSBs that are repaired by HR. Crucially, point mutations in MCM8–9 predicted to abolish helicase activity suppress ICL repair, suggesting that helicase activity is important for HR (Nishimura et al. 2012). One explanation is that MCM8–9 might facilitate postsynaptic DNA repair synthesis by unwinding D loops and enabling extension of the invading RAD51-coated DNA end (Fig. 1).
Figure 1.

Model for the concerted actions of HROB–MCM8–MCM and HELQ in postsynpatic DNA synthesis during HR.

Model for the concerted actions of HROB–MCM8–MCM and HELQ in postsynpatic DNA synthesis during HR. In this issue of Genes & Development, Hustedt et al. (2019) identify a new factor—HROB (HR OB-fold)—that functions closely with MCM8–9 in HR. Rationalizing that HR defects should cause sensitivity to inhibitors of ATR kinase and PARP, the investigators mined published CRISPR screens to identify new genes whose deletion sensitizes to both drug classes. This approach highlighted the uncharacterized C17ORF53 gene (renamed HROB) that, when disrupted in human cells or mice, causes pronounced HR defects. Disruption of mouse Hrob, for example, showed defects in meiosis and gametogenesis. Human HROB-deleted cells are defective in the HR step of ICL repair, and, whereas RAD51 loading is normal, RAD51 foci persist, hinting that HROB acts at a postsynaptic HR stage downstream from RAD51, similar to MCM8–9. In this light, HROB is epistatic with MCM8 and MCM9 in ICL repair and in HR-mediated repair of DSBs in a reporter cassette. Furthermore, residual DNA synthesis in MCM2-depleted cells, which depends on MCM8–9 (Natsume et al. 2017), requires HROB, with HROB and MCM8–9 acting epistatically in this context. A breakthrough came with the discovery that HROB recruits MCM8–9 to DNA lesions. HROB was found to physically interact with MCM8–9, and, excitingly, siRNA-mediated depletion of HROB compromised the accumulation of MCM8 at DNA repair foci but not vice versa. These data make a compelling case for HROB as an important HR factor acting with MCM8–9 to promote postsynaptic DNA repair synthesis. The investigators suggest that HROB acts by directly loading MCM8–9 onto HR intermediates, which draws interesting mechanistic parallels with MCM2–7, whose loading involves transient opening of a gate in the MCM2–7 hexamer (Deegan and Diffley 2016). It is not yet clear whether the MCM8–9 complex is hexameric in nature, nor is it known whether gate opening, perhaps mediated by HROB, is required for loading. Another notable finding is that HROB deletion in cells lacking the DNA helicase HELQ causes a stronger HR defect than in the single mutants. HELQ was known to be involved in HR during ICL repair (Takata et al. 2013) and in HR-mediated meiotic DSB repair (Adelman and Boulton 2010; Ward et al. 2010). In these contexts, HELQ deletion causes persistent RAD51 foci (Adelman and Boulton 2010). The new study shows that HELQ and HROB–MCM8–MCM9 function redundantly, perhaps representing parallel pathways for promoting DNA synthesis downstream from RAD51 (Fig. 1). How might these two pathways converge at the molecular level? Perhaps the simplest model is that unwinding of HR intermediates, such as D loops, requires the helicase activities of both HELQ and MCM8–9 to enable extension of the RAD51-coated DNA end. Such a model predicts that helicase-inactivating mutations in HELQ would phenocopy, at least partly, the gene deletion. This remains to be tested. It is interesting that HELQ can remove RAD51 from dsDNA in vitro independently of helicase activity, possibly by direct RAD51 binding (Adelman and Boulton 2010; Ward et al. 2010). Furthermore, HELQ interacts with the BCDX2 complex of RAD51 paralogs that may also have a RAD51-stripping activity (Adelman et al. 2013; Takata et al. 2013). It is conceivable, therefore, that the ability of HELQ to strip RAD51 off the terminus of the invading end in the D loop, perhaps together with BCDX2, facilitates postsynaptic DNA synthesis through freeing the terminus for primer extension. Such a model might be suggested if mammalian cells with helicase-inactivating HELQ mutations were HR-proficient. Whatever the case, the identification of HROB, working together with MCM8–9 and HELQ in facilitating postsynaptic DNA repair synthesis, sheds light on a poorly undertood aspect of HR.
  11 in total

1.  MCM8- and MCM9-deficient mice reveal gametogenesis defects and genome instability due to impaired homologous recombination.

Authors:  Malik Lutzmann; Corinne Grey; Sabine Traver; Olivier Ganier; Apolinar Maya-Mendoza; Noemie Ranisavljevic; Florence Bernex; Atsuya Nishiyama; Nathalie Montel; Elodie Gavois; Luc Forichon; Bernard de Massy; Marcel Méchali
Journal:  Mol Cell       Date:  2012-07-05       Impact factor: 17.970

2.  Mcm8 and Mcm9 form a complex that functions in homologous recombination repair induced by DNA interstrand crosslinks.

Authors:  Kohei Nishimura; Masamichi Ishiai; Kazuki Horikawa; Tatsuo Fukagawa; Minoru Takata; Haruhiko Takisawa; Masato T Kanemaki
Journal:  Mol Cell       Date:  2012-07-05       Impact factor: 17.970

Review 3.  MCM: one ring to rule them all.

Authors:  Tom D Deegan; John F X Diffley
Journal:  Curr Opin Struct Biol       Date:  2016-02-08       Impact factor: 6.809

Review 4.  Homologous recombination and human health: the roles of BRCA1, BRCA2, and associated proteins.

Authors:  Rohit Prakash; Yu Zhang; Weiran Feng; Maria Jasin
Journal:  Cold Spring Harb Perspect Biol       Date:  2015-04-01       Impact factor: 10.005

5.  Overlapping mechanisms promote postsynaptic RAD-51 filament disassembly during meiotic double-strand break repair.

Authors:  Jordan D Ward; Diego M Muzzini; Mark I R Petalcorin; Enrique Martinez-Perez; Julie S Martin; Paolo Plevani; Giuseppe Cassata; Federica Marini; Simon J Boulton
Journal:  Mol Cell       Date:  2010-01-29       Impact factor: 17.970

Review 6.  The MCM8/9 complex: A recent recruit to the roster of helicases involved in genome maintenance.

Authors:  Wezley C Griffin; Michael A Trakselis
Journal:  DNA Repair (Amst)       Date:  2019-02-05

7.  Human DNA helicase HELQ participates in DNA interstrand crosslink tolerance with ATR and RAD51 paralogs.

Authors:  Kei-ichi Takata; Shelley Reh; Junya Tomida; Maria D Person; Richard D Wood
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

8.  HELQ promotes RAD51 paralogue-dependent repair to avert germ cell loss and tumorigenesis.

Authors:  Carrie A Adelman; Rafal L Lolo; Nicolai J Birkbak; Olga Murina; Kenichiro Matsuzaki; Zuzana Horejsi; Kalindi Parmar; Valérie Borel; J Mark Skehel; Gordon Stamp; Alan D'Andrea; Alessandro A Sartori; Charles Swanton; Simon J Boulton
Journal:  Nature       Date:  2013-09-04       Impact factor: 49.962

9.  Acute inactivation of the replicative helicase in human cells triggers MCM8-9-dependent DNA synthesis.

Authors:  Toyoaki Natsume; Kohei Nishimura; Sheroy Minocherhomji; Rahul Bhowmick; Ian D Hickson; Masato T Kanemaki
Journal:  Genes Dev       Date:  2017-05-09       Impact factor: 11.361

10.  Control of homologous recombination by the HROB-MCM8-MCM9 pathway.

Authors:  Nicole Hustedt; Yuichiro Saito; Michal Zimmermann; Alejandro Álvarez-Quilón; Dheva Setiaputra; Salomé Adam; Andrea McEwan; Jing Yi Yuan; Michele Olivieri; Yichao Zhao; Masato T Kanemaki; Andrea Jurisicova; Daniel Durocher
Journal:  Genes Dev       Date:  2019-08-29       Impact factor: 11.361

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.